The drug company Merck announced Friday that its COVID-19 antiviral pill cuts the risk of hospitalization and death by 50% in people recently infected with the coronavirus.
Here & Now‘s Tonya Mosley speaks with Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital and dean of the National School of Tropical Medicine at Baylor College of Medicine.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.